- Home
- ARTV vs SNAL Comparison
ARTV vs SNAL Comparison
Compare ARTV & SNAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTV
- SNAL
- Stock Information
- Founded
- ARTV 2019
- SNAL 2000
- Country
- ARTV United States
- SNAL United States
- Employees
- ARTV N/A
- SNAL N/A
- Industry
- ARTV
- SNAL Computer Software: Prepackaged Software
- Sector
- ARTV
- SNAL Technology
- Exchange
- ARTV NYSE
- SNAL Nasdaq
- Market Cap
- ARTV 61.9M
- SNAL 59.1M
- IPO Year
- ARTV 2024
- SNAL 2022
- Fundamental
- Price
- ARTV $2.24
- SNAL $1.01
- Analyst Decision
- ARTV Strong Buy
- SNAL
- Analyst Count
- ARTV 7
- SNAL 0
- Target Price
- ARTV $20.00
- SNAL N/A
- AVG Volume (30 Days)
- ARTV 679.3K
- SNAL 64.0K
- Earning Date
- ARTV 05-22-2025
- SNAL 05-14-2025
- Dividend Yield
- ARTV N/A
- SNAL N/A
- EPS Growth
- ARTV N/A
- SNAL N/A
- EPS
- ARTV N/A
- SNAL 0.05
- Revenue
- ARTV $251,000.00
- SNAL $84,467,047.00
- Revenue This Year
- ARTV N/A
- SNAL $21.96
- Revenue Next Year
- ARTV N/A
- SNAL $22.77
- P/E Ratio
- ARTV N/A
- SNAL $20.29
- Revenue Growth
- ARTV N/A
- SNAL 38.69
- 52 Week Low
- ARTV $1.78
- SNAL $0.52
- 52 Week High
- ARTV $17.31
- SNAL $3.42
- Technical
- Relative Strength Index (RSI)
- ARTV N/A
- SNAL 43.56
- Support Level
- ARTV N/A
- SNAL $0.64
- Resistance Level
- ARTV N/A
- SNAL $1.39
- Average True Range (ATR)
- ARTV 0.00
- SNAL 0.14
- MACD
- ARTV 0.00
- SNAL 0.05
- Stochastic Oscillator
- ARTV 0.00
- SNAL 49.41
About ARTV ARTIVA BIOTHERAPEUTICS INC
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).
About SNAL Snail Inc.
Snail Inc is a global independent developer and publisher of interactive digital entertainment for consumers around the world, with a premier portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States.